Sprint Nextel Corporation (NYSE:S) dipped 0.82%, Boston Scientific Corporation (NYSE:BSX)

Posted by George Brook May 29, 2013 0 Comment 870 views


Sprint Nextel Corporation (NYSE:S): Tuesday’s trading session saw Sprint Nextel Corporation (NYSE:S) dipped 0.82%. The opening price of $7.32 climbed to an intraday high of $7.36 before settling down to close at $7.26 per share. Around 30.58 million shares were traded in the last trading session, which stood below the average volume of 70.76 million that was measured over 30 days.

Sprint Nextel Corporation (NYSE:S) is a holding company. Its operations are largely conducted via its subsidiaries. The company operates in two different segments: Wireline as well as Wireless. This communications company offers a variety of wireline and wireless communication services and products. It offers wireless as well as wireline data and voice transmission services to its subscribers across all the 50 states in the U.S, the United States Virgin Islands and Puerto Rico, under its corporate brand.

This includes Sprint, Boost Mobile, Nextel, Assurance Wireless and Virgin Mobile retail brands on networks that make use of third generation, code division multiple access, integrated Digital Enhanced Network or Internet protocol technologies.

Boston Scientific Corporation (NYSE:BSX): Tuesday’s trading session saw Boston Scientific Corporation (NYSE:BSX) gained 1.54%. The opening price of $9.19 climbed to an intraday high of $9.32 before settling down to close at $9.15 per share. Around 15.85 million shares were traded in the last trading session, which stood below the average volume of 20.35 million that was measured over 30 days.

Boston Scientific Corporation has received the CE Mark approval for the use of its GUIDE DBS System. This is the first deep brain stimulation visualization system in the world. The GUIDE DBS affords clinicians 3D visualization information that simulates the stimulation output. In effect, this may reduce the programming time and will also permit more accurate therapy targeting.

With the use of GUIDE DBS, it is possible for physicians to visualize the relative position of any lead location. Stimulation field models can thus be utilized within the brain. This innovative GUIDE DBS technology, in combination with the Vercise DBS System, was specifically developed to provide neurosurgeons, neurologists and their patients with the most advanced deep brain stimulation technology.


About George Brook

George Brook covers money and politics for GDP Insider. George is a veteran journalist who has also covered Congress, national political conventions and presidential politics. George also covers the White House as well as economic and domestic policy for GDP insider. George's reporting has won numerous awards, including two Scripps Howard awards, two National Headliners, two Gerald Loeb Awards, as well as honors from Sigma Delta Chi and the National Press Club.

View all post by George Brook Visit author's website

Write Your Comment